H-Index
70
Scimago Lab
powered by Scopus
Clarivate
Analytics
Formerly the IP & Science
business of Thomson Reuters

Logo




eISSN: 1643-3750

Get your full text copy in PDF

Clinical importnace of the isotype of anticariolipin antibodies in patients with connective tissue diseases

Lidia Ostanek, Irena Fiedorowicz-Fabrycy

Med Sci Monit 1997; 3(6): CR835-839

ID: 501794


The purpose of this work was to evaluate the frequency of occurrence of high anticardiolipinic antibody titre (aCL) class IgG and IgM in patients with different systemic connective tissue diseases and determination of the relationship between chosen clinical symptoms and isotype of existing antibodies. 132 patients, including 119 women and 13 men at the age of 20-74 (average age 49.8), with different systemic connective tissue diseases, were examined. Anticardiolipinic antibodies were marked with the use of ELISA method with the application of tests produced by SIGMA. High titres of aCL were found in 35 examined patients (26.5%), in that number 18 (13.6%) were high values of aCL from IgG class, in 11 (9.3%) of aCL from IgM class and in 6 (4.5%) high titres of aCL of both classes (IgG+IgM) Secondary antiphospolipidic anatomosis was diagnosed in 23 patients according to Harris criteria. Skin changes were the most common clinical symptoms and were diagnosed in 17 patients with high titre of aCL. Neurological disturbances were observed in 12 patients, cardiological complications - in 10, thrombosis - in 5. Obstetrical failure occurred in 9 patients. In 23 patients thrombocytopenia occurred, in 10 - leucopenia, in 10 - APTT elongation, in 8 - presence of lupous anticoagulant and in 3 - false positive Wasserman's reactions. Most clinical symptoms, as well as deviations in immunological and haematological examinations, correlated with high class IgG aCL titres.

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree